Thomas M. Ross - 12 Nov 2021 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
EVP, Global Sales
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
MXCT
Transactions as of
12 Nov 2021
Net transactions value
-$1,434,991
Form type
4
Filing time
16 Nov 2021, 18:10:49 UTC
Previous filing
11 Aug 2021
Next filing
29 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $35,776 +42,590 $0.8400 42,590 12 Nov 2021 Direct
transaction MXCT Common Stock Sale $539,189 -42,590 -100% $12.66 0 12 Nov 2021 Direct F1
transaction MXCT Common Stock Options Exercise $43,136 +51,352 $0.8400 51,352 15 Nov 2021 Direct
transaction MXCT Common Stock Sale $624,440 -51,352 -100% $12.16 0 15 Nov 2021 Direct F2
transaction MXCT Common Stock Options Exercise $26,177 +31,163 $0.8400 31,163 16 Nov 2021 Direct
transaction MXCT Common Stock Sale $376,449 -31,163 -100% $12.08 0 16 Nov 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -42,590 -23% $0.000000 139,515 12 Nov 2021 Common Stock 42,590 $0.8400 Direct F4
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -51,352 -37% $0.000000 88,163 15 Nov 2021 Common Stock 51,352 $0.8400 Direct F4
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -31,163 -35% $0.000000 57,000 16 Nov 2021 Common Stock 31,163 $0.8400 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.56 to $12.765, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.03 to $12.615, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4 This option is fully vested and exercisable.